HomeALT • NASDAQ
add
Altimmune Inc
Previous close
$6.65
Day range
$5.93 - $6.71
Year range
$5.28 - $12.34
Market cap
424.62M USD
Avg Volume
2.09M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 5.00K | -86.49% |
Operating expense | 5.09M | 17.50% |
Net income | -23.18M | 26.74% |
Net profit margin | -463.60K | -442.12% |
Earnings per share | -0.33 | -0.33% |
EBITDA | -24.83M | -28.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 131.89M | -33.33% |
Total assets | 139.31M | -33.87% |
Total liabilities | 15.80M | -4.49% |
Total equity | 123.51M | — |
Shares outstanding | 72.35M | — |
Price to book | 3.89 | — |
Return on assets | -43.29% | — |
Return on capital | -48.07% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -23.18M | 26.74% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1997
Headquarters
Website
Employees
59
